Hypocretin/orexin deficiency decreases cocaine abuse liability

Nadia Steiner, Clara Rossetti, Takeshi Sakurai, Masashi Yanagisawa, Luis de Lecea, Pierre J. Magistretti, Olivier Halfon, Benjamin Boutrel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Compelling evidence indicates that hypocretin/orexin signaling regulates arousal, stress and reward-seeking behaviors. However, most studies on drug reward-related processes have so far described the effects of pharmacological blockers disrupting hypocretin/orexin transmission. We report here an extensive study on cocaine-related behaviors in hypocretin/orexin-deficient mice (KO) and their heterozygous (HET) and wildtype (WT) littermates. We evaluated behavioral sensitization following repeated administrations and preference for an environment repeatedly paired with cocaine injections (15 mg/kg). Mice were also trained to self-administer cocaine (0.5–1.5 mg/kg/infusion). Our observations show that whereas all mice exhibited quite similar responses to acute administration of cocaine, only Hcrt KO mice exhibited reduced cocaine-seeking behaviors following a period of abstinence or extinction, and reduced cocaine incubation craving. Further, if the present findings confirm that Hcrt deficient mice may display a hypoactive phenotype, possibly linked to a reduced alertness concomitant to a decreased exploration of their environment, hypocretin/orexin defiency did not cause any attentional deficit. We thus report that innate disruption of hypocretin/orexin signaling moderately alters cocaine reward but significantly reduces long-term affective dependence that may explain the lack of relapse for cocaine seeking seen in Hcrt KO mice. Overall, with blunted cocaine intake at the highest concentration and reduced responsiveness to cocaine cues after prolonged abstinence, our findings suggest that hypocretin deficient mice may display signs of resilience to cocaine addiction.

Original languageEnglish (US)
Pages (from-to)395-403
Number of pages9
JournalNeuropharmacology
Volume133
DOIs
StatePublished - May 1 2018

Fingerprint

Cocaine-Related Disorders
Cocaine
Reward
Orexins
Arousal
Cues
Pharmacology
Phenotype
Recurrence

Keywords

  • Cocaine
  • Hypocretin
  • Motivation
  • Orexin
  • Relapse
  • Saccharine

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Steiner, N., Rossetti, C., Sakurai, T., Yanagisawa, M., de Lecea, L., Magistretti, P. J., ... Boutrel, B. (2018). Hypocretin/orexin deficiency decreases cocaine abuse liability. Neuropharmacology, 133, 395-403. https://doi.org/10.1016/j.neuropharm.2018.02.010

Hypocretin/orexin deficiency decreases cocaine abuse liability. / Steiner, Nadia; Rossetti, Clara; Sakurai, Takeshi; Yanagisawa, Masashi; de Lecea, Luis; Magistretti, Pierre J.; Halfon, Olivier; Boutrel, Benjamin.

In: Neuropharmacology, Vol. 133, 01.05.2018, p. 395-403.

Research output: Contribution to journalArticle

Steiner, N, Rossetti, C, Sakurai, T, Yanagisawa, M, de Lecea, L, Magistretti, PJ, Halfon, O & Boutrel, B 2018, 'Hypocretin/orexin deficiency decreases cocaine abuse liability', Neuropharmacology, vol. 133, pp. 395-403. https://doi.org/10.1016/j.neuropharm.2018.02.010
Steiner N, Rossetti C, Sakurai T, Yanagisawa M, de Lecea L, Magistretti PJ et al. Hypocretin/orexin deficiency decreases cocaine abuse liability. Neuropharmacology. 2018 May 1;133:395-403. https://doi.org/10.1016/j.neuropharm.2018.02.010
Steiner, Nadia ; Rossetti, Clara ; Sakurai, Takeshi ; Yanagisawa, Masashi ; de Lecea, Luis ; Magistretti, Pierre J. ; Halfon, Olivier ; Boutrel, Benjamin. / Hypocretin/orexin deficiency decreases cocaine abuse liability. In: Neuropharmacology. 2018 ; Vol. 133. pp. 395-403.
@article{57a5e896ab784959b493a522c328f455,
title = "Hypocretin/orexin deficiency decreases cocaine abuse liability",
abstract = "Compelling evidence indicates that hypocretin/orexin signaling regulates arousal, stress and reward-seeking behaviors. However, most studies on drug reward-related processes have so far described the effects of pharmacological blockers disrupting hypocretin/orexin transmission. We report here an extensive study on cocaine-related behaviors in hypocretin/orexin-deficient mice (KO) and their heterozygous (HET) and wildtype (WT) littermates. We evaluated behavioral sensitization following repeated administrations and preference for an environment repeatedly paired with cocaine injections (15 mg/kg). Mice were also trained to self-administer cocaine (0.5–1.5 mg/kg/infusion). Our observations show that whereas all mice exhibited quite similar responses to acute administration of cocaine, only Hcrt KO mice exhibited reduced cocaine-seeking behaviors following a period of abstinence or extinction, and reduced cocaine incubation craving. Further, if the present findings confirm that Hcrt deficient mice may display a hypoactive phenotype, possibly linked to a reduced alertness concomitant to a decreased exploration of their environment, hypocretin/orexin defiency did not cause any attentional deficit. We thus report that innate disruption of hypocretin/orexin signaling moderately alters cocaine reward but significantly reduces long-term affective dependence that may explain the lack of relapse for cocaine seeking seen in Hcrt KO mice. Overall, with blunted cocaine intake at the highest concentration and reduced responsiveness to cocaine cues after prolonged abstinence, our findings suggest that hypocretin deficient mice may display signs of resilience to cocaine addiction.",
keywords = "Cocaine, Hypocretin, Motivation, Orexin, Relapse, Saccharine",
author = "Nadia Steiner and Clara Rossetti and Takeshi Sakurai and Masashi Yanagisawa and {de Lecea}, Luis and Magistretti, {Pierre J.} and Olivier Halfon and Benjamin Boutrel",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.neuropharm.2018.02.010",
language = "English (US)",
volume = "133",
pages = "395--403",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Hypocretin/orexin deficiency decreases cocaine abuse liability

AU - Steiner, Nadia

AU - Rossetti, Clara

AU - Sakurai, Takeshi

AU - Yanagisawa, Masashi

AU - de Lecea, Luis

AU - Magistretti, Pierre J.

AU - Halfon, Olivier

AU - Boutrel, Benjamin

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Compelling evidence indicates that hypocretin/orexin signaling regulates arousal, stress and reward-seeking behaviors. However, most studies on drug reward-related processes have so far described the effects of pharmacological blockers disrupting hypocretin/orexin transmission. We report here an extensive study on cocaine-related behaviors in hypocretin/orexin-deficient mice (KO) and their heterozygous (HET) and wildtype (WT) littermates. We evaluated behavioral sensitization following repeated administrations and preference for an environment repeatedly paired with cocaine injections (15 mg/kg). Mice were also trained to self-administer cocaine (0.5–1.5 mg/kg/infusion). Our observations show that whereas all mice exhibited quite similar responses to acute administration of cocaine, only Hcrt KO mice exhibited reduced cocaine-seeking behaviors following a period of abstinence or extinction, and reduced cocaine incubation craving. Further, if the present findings confirm that Hcrt deficient mice may display a hypoactive phenotype, possibly linked to a reduced alertness concomitant to a decreased exploration of their environment, hypocretin/orexin defiency did not cause any attentional deficit. We thus report that innate disruption of hypocretin/orexin signaling moderately alters cocaine reward but significantly reduces long-term affective dependence that may explain the lack of relapse for cocaine seeking seen in Hcrt KO mice. Overall, with blunted cocaine intake at the highest concentration and reduced responsiveness to cocaine cues after prolonged abstinence, our findings suggest that hypocretin deficient mice may display signs of resilience to cocaine addiction.

AB - Compelling evidence indicates that hypocretin/orexin signaling regulates arousal, stress and reward-seeking behaviors. However, most studies on drug reward-related processes have so far described the effects of pharmacological blockers disrupting hypocretin/orexin transmission. We report here an extensive study on cocaine-related behaviors in hypocretin/orexin-deficient mice (KO) and their heterozygous (HET) and wildtype (WT) littermates. We evaluated behavioral sensitization following repeated administrations and preference for an environment repeatedly paired with cocaine injections (15 mg/kg). Mice were also trained to self-administer cocaine (0.5–1.5 mg/kg/infusion). Our observations show that whereas all mice exhibited quite similar responses to acute administration of cocaine, only Hcrt KO mice exhibited reduced cocaine-seeking behaviors following a period of abstinence or extinction, and reduced cocaine incubation craving. Further, if the present findings confirm that Hcrt deficient mice may display a hypoactive phenotype, possibly linked to a reduced alertness concomitant to a decreased exploration of their environment, hypocretin/orexin defiency did not cause any attentional deficit. We thus report that innate disruption of hypocretin/orexin signaling moderately alters cocaine reward but significantly reduces long-term affective dependence that may explain the lack of relapse for cocaine seeking seen in Hcrt KO mice. Overall, with blunted cocaine intake at the highest concentration and reduced responsiveness to cocaine cues after prolonged abstinence, our findings suggest that hypocretin deficient mice may display signs of resilience to cocaine addiction.

KW - Cocaine

KW - Hypocretin

KW - Motivation

KW - Orexin

KW - Relapse

KW - Saccharine

UR - http://www.scopus.com/inward/record.url?scp=85042365281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042365281&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2018.02.010

DO - 10.1016/j.neuropharm.2018.02.010

M3 - Article

C2 - 29454841

AN - SCOPUS:85042365281

VL - 133

SP - 395

EP - 403

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -